Blog Archives

Blog

Secondary Intelligence™: Empowering Decision-Making in Drug Development & Safety Assessment

Adverse effects of drugs pose potential harm to patients and can hinder or halt the…

CertaraAugust 11, 2023

Blog

Model-Informed Formulation Development: Insights from a Case Study

In a captivating webinar led by industry experts, Dr. Swati Jaiswal, Senior PBPK Consultant at…

CertaraAugust 10, 2023

Blog

Drug Manufacturers’ Recent Drop in Insulin Prices in the United States

The prevalence of diabetes in the US is incredibly high and affects more than 10%…

CertaraAugust 3, 2023

Blog

Simcyp™ Compound Summaries Library: What is it & why should you use it?

In the world of pharmacokinetic/dynamic (PBPK/PD) modelling, compound PBPK models are incorporated into compound files…

CertaraJuly 21, 2023

Blog

Change Management – An Important Part of Good Manufacturing Practice (GMP)

You are having a good day as a quality assurance professional at a small pharmaceutical…

CertaraJuly 14, 2023

Blog

Chemistry in the Cloud

How does the cloud help you answer your pressing day-to-day pharmaceutical R&D questions faster, and…

CertaraJune 9, 2023

Blog

Japan’s Approach to Pediatric Drug Development: What You Need to Know

Access to safe and effective medications is critical for pediatric patients, yet 60-70% of medicines…

CertaraMay 22, 2023

Blog

Creation of a Scientific Hypothesis – For optimization of drug compounds | Chemaxon

A well-formulated hypothesis is essential to the success of the drug discovery process.

CertaraMay 19, 2023

Blog

Key Properties in Drug Design | Predicting Lipophilicity, pKa and Solubility

Discover how Chemaxon's predictive models for lipophilicity, pKa, and solubility can accurately predict key molecular…

CertaraMay 12, 2023

Blog

What is a Global Risk Mitigation Plan & how can you use it to ensure a successful drug launch?

A Global Risk Mitigation Plan (GRMP) is a critical step in drug development as it…

CertaraMay 4, 2023

Blog

Secondary Intelligence™: Empowering Decision-Making in Drug Development & Safety Assessment

Model-Informed Formulation Development: Insights from a Case Study

Drug Manufacturers’ Recent Drop in Insulin Prices in the United States

Simcyp™ Compound Summaries Library: What is it & why should you use it?

Change Management – An Important Part of Good Manufacturing Practice (GMP)

Chemistry in the Cloud

Japan’s Approach to Pediatric Drug Development: What You Need to Know

Creation of a Scientific Hypothesis – For optimization of drug compounds | Chemaxon

Key Properties in Drug Design | Predicting Lipophilicity, pKa and Solubility

What is a Global Risk Mitigation Plan & how can you use it to ensure a successful drug launch?

Newsletter sign up

Quick links

Solutions

Contact